ResMed Inc (RMD)
243.60
+2.05
(+0.85%)
USD |
NYSE |
Nov 21, 16:00
244.95
+1.35
(+0.55%)
Pre-Market: 20:00
ResMed Max Drawdown (5Y): 53.98% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 53.98% |
| September 30, 2024 | 53.98% |
| August 31, 2024 | 53.98% |
| July 31, 2024 | 53.98% |
| June 30, 2024 | 53.98% |
| May 31, 2024 | 53.98% |
| April 30, 2024 | 53.98% |
| March 31, 2024 | 53.98% |
| February 29, 2024 | 53.98% |
| January 31, 2024 | 53.98% |
| December 31, 2023 | 53.98% |
| November 30, 2023 | 53.98% |
| October 31, 2023 | 53.98% |
| September 30, 2023 | 53.42% |
| August 31, 2023 | 45.46% |
| July 31, 2023 | 35.28% |
| June 30, 2023 | 35.28% |
| May 31, 2023 | 35.28% |
| April 30, 2023 | 35.28% |
| March 31, 2023 | 35.28% |
| February 28, 2023 | 35.28% |
| January 31, 2023 | 35.28% |
| December 31, 2022 | 35.28% |
| November 30, 2022 | 35.28% |
| October 31, 2022 | 35.28% |
| Date | Value |
|---|---|
| September 30, 2022 | 35.28% |
| August 31, 2022 | 35.28% |
| July 31, 2022 | 35.28% |
| June 30, 2022 | 35.28% |
| May 31, 2022 | 35.28% |
| April 30, 2022 | 35.26% |
| March 31, 2022 | 35.26% |
| February 28, 2022 | 35.26% |
| January 31, 2022 | 35.26% |
| December 31, 2021 | 35.26% |
| November 30, 2021 | 35.26% |
| October 31, 2021 | 35.26% |
| September 30, 2021 | 35.26% |
| August 31, 2021 | 35.26% |
| July 31, 2021 | 35.26% |
| June 30, 2021 | 35.26% |
| May 31, 2021 | 35.26% |
| April 30, 2021 | 35.26% |
| March 31, 2021 | 35.26% |
| February 28, 2021 | 35.26% |
| January 31, 2021 | 35.26% |
| December 31, 2020 | 35.26% |
| November 30, 2020 | 35.26% |
| October 31, 2020 | 35.26% |
| September 30, 2020 | 35.26% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
33.25%
Minimum
Nov 2019
53.98%
Maximum
Oct 2023
39.66%
Average
35.27%
Median
Max Drawdown (5Y) Benchmarks
| Boston Scientific Corp | 43.49% |
| Globus Medical Inc | 47.91% |
| Abbott Laboratories | 33.88% |
| Haemonetics Corp | 68.62% |
| Becton Dickinson & Co | 29.62% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 0.1261 |
| Beta (5Y) | 0.6862 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 33.06% |
| Historical Sharpe Ratio (5Y) | 0.2717 |
| Historical Sortino (5Y) | 0.4374 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 14.09% |